XML 29 R19.htm IDEA: XBRL DOCUMENT v3.25.3
Insider Trading Arrangements
 3 Months Ended
Sep. 30, 2025
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
During the quarter ended September 30, 2025, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted, modified or terminated the contracts, instructions, or written plans for the purchase or sale of our securities set forth in the table below:
Name and PositionActionAdoption/Termination Date
Type of Trading Arrangement: Rule 10b5-1(1)
Total Shares of Common Stock to be SoldExpiration Date
Martha Morrell, Chief Medical Officer
AdoptionSeptember 15, 2025X
91,669(2)
December 31, 2026

(1) Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
(2) Including the exercise and sale of up to 34,219 shares of the Company’s common stock subject to stock options.
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Martha Morrell [Member]  
Trading Arrangements, by Individual  
Name Martha Morrell
Title Chief Medical Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date September 15, 2025
Expiration Date December 31, 2026
Arrangement Duration 472 days
Aggregate Available 91,669
Martha Morrell Trading Arrangement, Stock Options [Member] | Martha Morrell [Member]  
Trading Arrangements, by Individual  
Aggregate Available 34,219